Aster Capital Management (Difc) LTD Acadia Pharmaceuticals Inc Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 40,609 shares of ACAD stock, worth $802,839. This represents 0.28% of its overall portfolio holdings.
Number of Shares
40,609Holding current value
$802,839% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
306Shares Held
157MCall Options Held
828KPut Options Held
317K-
Baker Bros. Advisors LP New York, NY42.9MShares$848 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$276 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$238 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$172 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$144 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $3.2B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...